The Lancet Respiratory Medicine

Visão geral
Metrics
Identidade
Ver todos

Qualis

A1

código do país

NL

tipo

journal

publicação venue de

Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. 23:S2213-2600. 2023-01-01
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study. 1:1-14. 2023-01-01
Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study. 11:449-476. 2023-01-01
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. 10:1137-1146. 2022-01-01
Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial. 10:327-336. 2022-01-01
Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial. 10:985-996. 2022-01-01
Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care. 22:S2213-2600(22)0. 2022-01-01
Incidence of death or disability at 6 months after extracorporeal membrane oxygenation in Australia: a prospective, multicentre, registry-embedded cohort study. 10:1038-1048. 2022-01-01
Long COVID: systemic inflammation and obesity as therapeutic targets. 10:726-727. 2022-01-01
Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study. 10:1147-1159. 2022-01-01
The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study. 21:00536-1. 2022-01-01
Battling COVID-19-related mortality: from a fight for ventilators to a cry for oxygen. 9:939-941. 2021-01-01
COVID-19 hospital admissions: Brazil's first and second waves compared. 9:e82-e83. 2021-01-01
COVID-19: a heavy toll on health-care workers. 9:226-228. 2021-01-01
Characterisation of the first 250-000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. 1:1-418. 2021-01-01
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial. 21:00222-00228. 2021-01-01
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. 21:1-12. 2021-01-01
From female warriors in the rainforest to infectious disease specialists: COVID-19 in the Amazon. 5:S2213-2600(21)0. 2021-01-01
Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. 9:1030-1049. 2021-01-01
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial. 9:957-968. 2021-01-01
Instrumental dead space in ventilator management - Authors' reply. 9:e23. 2021-01-01
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial. 1:1-1. 2021-01-01
Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts. 9:1377-1386. 2021-01-01
Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study. 9:239-250. 2021-01-01
Recovery after prolonged ICU treatment in patients with COVID-19. 9:812-814. 2021-01-01
Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma (BT10+): a follow-up of three randomised controlled trials. 20:1-10. 2021-01-01
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial. 9:522-532. 2021-01-01
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial. 9:573-584. 2021-01-01
Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study.. 9:1101-1110. 2021-01-01
A critical approach to personalised medicine in acute respiratory distress syndrome.. 8:218-219. 2020-01-01
Delivering evidence-based critical care for mechanically ventilated patients with COVID-19. 2600:30266-6. 2020-01-01
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis. 8:383-394. 2020-01-01
Expression quantitative trait locus fine mapping of the 17q12-21 asthma locus in African American children: a genetic association and gene expression study. 8:482-492. 2020-01-01
Gender Equity in Interstitial Lung Diseases. 20:310. 2020-01-01
Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. 8:585-596. 2020-01-01
Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial. 8:192-201. 2020-01-01
Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study. 139-148. 2020-01-01

tem uma área de assunto

publisher

Elsevier BV

is open access

False invalid format

is in DOAJ

False invalid format